Logo
Apparel & Fashion

Loading subcategories...

View More

Description

Imatib Capsules 100mg contain Imatinib, a targeted therapy medication specifically designed to inhibit tyrosine kinases that drive cancer cell proliferation. This sophisticated mechanism makes the treatment highly effective for managing chronic myeloid leukemia, gastrointestinal stromal tumors, and other rare cancers including dermatofibrosarcoma protuberans and systemic mastocytosis. The capsules are precisely formulated to ensure optimal dosing accuracy and maximum bioavailability, delivering consistent therapeutic results across diverse patient populations. Trusted by medical professionals globally, Imatib has established itself as a fundamental component in modern oncology treatment protocols, providing both clinical effectiveness and improved quality of life for patients confronting these serious health challenges.

Healthcare institutions worldwide incorporate Imatib Capsules into their comprehensive cancer treatment programs, particularly for chronic myeloid leukemia affecting w...
Imatib Capsules 100mg contain Imatinib, a targeted therapy medication specifically designed to inhibit tyrosine kinases that drive cancer cell proliferation. This sophisticated mechanism makes the treatment highly effective for managing chronic myeloid leukemia, gastrointestinal stromal tumors, and other rare cancers including dermatofibrosarcoma protuberans and systemic mastocytosis. The capsules are precisely formulated to ensure optimal dosing accuracy and maximum bioavailability, delivering consistent therapeutic results across diverse patient populations. Trusted by medical professionals globally, Imatib has established itself as a fundamental component in modern oncology treatment protocols, providing both clinical effectiveness and improved quality of life for patients confronting these serious health challenges.

Healthcare institutions worldwide incorporate Imatib Capsules into their comprehensive cancer treatment programs, particularly for chronic myeloid leukemia affecting white blood cell production and gastrointestinal stromal tumors developing in the digestive system. Medical specialists also prescribe this treatment for dermatofibrosarcoma protuberans, an uncommon skin cancer, and systemic mastocytosis, a complex disorder involving abnormal mast cell accumulation. The pharmaceutical distribution industry, hospital supply networks, and specialized oncology clinics rely on consistent access to these capsules to meet growing patient needs. Importers, distributors, and wholesalers play a crucial role in maintaining supply chain integrity, ensuring this vital treatment reaches healthcare providers and patients efficiently.

Medical suppliers and distributors can confidently include Imatib Capsules in their portfolio as a proven therapeutic with strong market acceptance and clinical validation. Manufactured under rigorous quality control systems, these capsules guarantee batch-to-batch consistency, patient safety, and treatment efficacy. The product's reliability and demonstrated clinical benefits make it a valuable addition to any medical supply inventory, supporting healthcare providers in delivering effective cancer care. By offering this established treatment option, distributors contribute to improved patient outcomes while building sustainable partnerships with medical institutions committed to advancing cancer treatment.

Key Features:
- Each capsule contains precisely 100mg of Imatinib for accurate dosing
- Specifically targets tyrosine kinases to inhibit cancer cell growth mechanisms
- Produced under comprehensive quality assurance protocols and standards
- Effective for multiple cancer types including CML and GIST
- Consistent formulation ensures reliable therapeutic performance

Benefits:
- Provides targeted action against specific cancer-driving proteins
- Supports effective disease management across multiple cancer types
- Delivers consistent therapeutic outcomes through precise formulation
- Meets international quality standards for safety and efficacy
- Enables reliable supply for healthcare providers and patients

Specifications

Additional Information
Country of OriginIndia
CustomisableNo

Application

Imatib Capsules 100mg serve as essential therapy for chronic myeloid leukemia, targeting specific proteins that drive cancer cell growth in blood and bone marrow. These capsules provide reliable disease management in hospital oncology departments and cancer treatment centers, offering consistent therapeutic outcomes for patients with this serious condition. Medical distributors value these capsules for their proven efficacy in managing gastrointestinal stromal tumors when surgical intervention isn't feasible. Healthcare facilities worldwide incorporate this treatment into their cancer care protocols, trusting its ability to control tumor growth and improve patient quality of life through targeted molecular action. Pharmaceutical suppliers and medical distributors can depend on Imatib Capsules for meeting the demanding requirements of oncology practice. The product's consistent quality and compliance with international standards make it suitable for bulk supply to hospitals, specialized clinics, and pharmacy networks. Healthcare providers trust this treatment for its demonstrated safety profile and therapeutic reliability across multiple cancer types. The capsules support comprehensive cancer care programs while maintaining strict quality assurance throughout the supply chain. - Treatment of chronic myeloid leukemia in both adult and pediatric patient populations - Management of gastrointestinal stromal tumors that cannot be surgically removed or have spread - Therapy for dermatofibrosarcoma protuberans when surgical options are limited - Control of systemic mastocytosis cases with aggressive cellular proliferation - Adjuvant treatment following surgical removal of GIST to prevent cancer recurrence

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

Biogenix Pharma UK Limited, Maharashtra
TruBasic
IndiaMaharashtra, India
Manufacturer
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Imatib Capsules 100mg for CML GIST Cancer Treatment

Imatib Capsules 100mg provide targeted oncology treatment for chronic myeloid leukemia and gastrointestinal stromal tumors. These reliable capsules deliver precise Imatinib dosing for effective cancer therapy in clinical settings.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

Biogenix Pharma UK Limited
Verified
IndiaMaharashtra, India
Manufacturer

More Products From Supplier